Compare Mesoblast Limited (MESO) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs ON Holding AG — how do they compare? Mesoblast Limited trades at $16.96 (market cap $2.21B), while ON Holding AG trades at $31.15 (market cap $10.33B). The key difference: ON Holding AG is far larger — about 4.7× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| MESO | ONON | |
|---|---|---|
Market Cap | $2.21B | $10.33B |
Sector | Technology | Technology |
52-Week High | $20.96 | $50.63 |
52-Week Low | $12.88 | $30.91 |
Enterprise Value | $2.21B | $9.47B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
